Male breast cancer is an extremely rare malignancy. We treated three male breast cancer patients. All three patients showed clinical N0 and received sentinel lymph node biopsy. Because the sentinel lymph node was positive for metastasis in one patient, a total mastectomy with axillary lymph node dissection was performed. The other two patients were negative for sentinel lymph node metastasis, and a simple mastectomy was performed. Two of the patients were postoperatively treated with tamoxifen; another patient was treated with adjuvant chemotherapy using taxotere and cyclophosphamide before tamoxifen. There was no recurrence in any of the three patients during an average follow-up period of 56.7 months (range 11.8–80.3). A sentinel lymph no...
Breast cancer in men is an uncommon disease. Because of its rarity little is known about its aetiolo...
Male breast cancer (MBC) accounts for approximately 1% of all breast cancers, limiting the data char...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Male breast cancer is rare disease and it represents 1 % breast cancer. Invasive ductal cancer domin...
Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a trend to MB...
Background: Breast cancer in men is a rare disease that represents <1% of cases. Currently, there is...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Male breast cancer (MBC) is rare, with an estimated 145 men diagnosed in Australia this year and up ...
BACKGROUND AND OBJECTIVESOptimal management if male breast cancer (MBC) is not clearly established a...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Male breast cancer is an uncommon disease accounting for only 1% of all breast cancers. We present t...
Background: Male breast cancer (MBC) is a rare disease representing less than 1% of all malignancies...
Breast cancer (BC) is an epithelial neoplastic disease that usually begins in the ducts or lobules o...
Breast cancer in men is an uncommon disease. Because of its rarity little is known about its aetiolo...
Male breast cancer (MBC) accounts for approximately 1% of all breast cancers, limiting the data char...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Male breast cancer is rare disease and it represents 1 % breast cancer. Invasive ductal cancer domin...
Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a trend to MB...
Background: Breast cancer in men is a rare disease that represents <1% of cases. Currently, there is...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Male breast cancer (MBC) is rare, with an estimated 145 men diagnosed in Australia this year and up ...
BACKGROUND AND OBJECTIVESOptimal management if male breast cancer (MBC) is not clearly established a...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Male breast cancer is an uncommon disease accounting for only 1% of all breast cancers. We present t...
Background: Male breast cancer (MBC) is a rare disease representing less than 1% of all malignancies...
Breast cancer (BC) is an epithelial neoplastic disease that usually begins in the ducts or lobules o...
Breast cancer in men is an uncommon disease. Because of its rarity little is known about its aetiolo...
Male breast cancer (MBC) accounts for approximately 1% of all breast cancers, limiting the data char...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...